Association between metabolic syndrome and male lower urinary tract symptoms in Japanese subjects using three sets of criteria for metabolic syndrome and international prostate symptom score

Urology

Volumn 77, Issue 6, 2011, Pages 1432-1438

  Ohgaki, Kenji ^a,b,c   Hikima, Norio ^a,b,c   Horiuchi, Kazutaka ^a,b,c   Kondo, Yukihiro ^a,b,c  

^a NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^b Ookurayama Memorial Hospital   (Japan)

^c NIPPON MEDICAL SCHOOL GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; JAPANESE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICTURITION DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

AGED; AGING; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; PROSTATE; PROSTATIC DISEASES; QUESTIONNAIRES; RISK FACTORS; URINATION DISORDERS; UROLOGY;

EID: 79957889065     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.12.024     Document Type: Article

References (29)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607. (Pubitemid 19004941)
2. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 1997;107:239-246.
3. Matsuzawa YM. Pathophysiology and molecular mechanism of visceral fat syndrome: the Japanese experience. Diabetes/Metab Rev. 1997;13:3-13.
4. Committee on Criteria for Metabolic Syndrome. Definition and criteria for metabolic syndrome. J Jpn Soc Intern Med. 2005;94:794-809 (in Japanese).
5. Abrams P, Cardozo L, Fall M, et al. Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn. 2002;21:167-178. (Pubitemid 34195211)
6. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549-1553.
7. Meigs JB, Mohr B, Barry MJ, et al. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001;54:935-944. (Pubitemid 32771319)
8. Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press. 1999;8:29-36. (Pubitemid 29278945)
9. Rohrmann S, Smit E, Giovannucci E, et al. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes. 2005;29:310-316. (Pubitemid 40333230)
10. McVary KT, Rademaker A, Lloyd GL, et al. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2005;174(4 Pt. 1):1327-1433.
11. Dal Maso L, Zucchetto A, Tavani A, et al. Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia. Int J Cancer. 2006;118:2632-2635.
12. Temml C, Obermayr R, Marszalek M, et al. Are lower urinary tract symptoms influenced by metabolic syndrome? Urology. 2009;73:544-548.
13. Park HK, Lee HW, Lee KS, et al, for the Korean Longitudinal Study on Health and Aging. Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population. Urology. 2008;72:556-560.
14. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new worldwide definition: a consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
15. Grundy SM, Cleeman JI, Daniels SR, et al, for the American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation. 2005;112:2735-2752. (Pubitemid 41532612)
16. Andersson SO, RashidKhani B, Karlberg L, et al. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men. BJU Int. 2004;94:327-331. (Pubitemid 39120173)
17. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637-649. (Pubitemid 37542920)
18. Ponholzer A, Temml C, Wehrberger C, et al. The association between vascular risk factors and lower urinary tract symptoms in both sexes. Eur Urol. 2006;50:581-586. (Pubitemid 44189048)
19. Wong SY, Woo J, Hong A, et al. Risk factors for lower urinary tract symptoms in southern Chinese men. Urology. 2006;68:1009-1014. (Pubitemid 44750133)
20. Rahman NU, Phonsombat S, Bochinski D, et al. An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int. 2007;100:658-663. (Pubitemid 47205488)
21. Persson K, Pandita RK, Spitsbergen JM, et al. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am J Physiol. 1998;275:R1366-R1373.
22. Azadzoi KM, Yalla SV, Siroky MB. Oxidative stress and neurodegeneration in the ischemic overactive bladder. J Urol. 2007;178:710-715. (Pubitemid 47030477)
23. WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
24. Chyou PH, Nomura AMY, Stemmermann GN, et al. A prospective study of alcohol, diet, and other lifestyle factors on relation to obstructive uropathy. Prostate. 1993;22:253-264. (Pubitemid 23184736)
25. Magi-Galluzi C, Parsons JK, Fedor H, et al. The prevalence and extent of autopsy benign prostatic hyperplasia (BPH) is less in Southeast Asian men than North American men. J Urol. 2004;171 (Suppl):406.
26. Jin B, Turner L, Zhou Z, et al. Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab. 1999;84:3613-3619. (Pubitemid 30645214)
27. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007;178:395-401. (Pubitemid 47030484)
28. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356-359.
29. Kuzuya M, Ando F, Iguchi A, et al. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis. 2007;191:305-312. (Pubitemid 46400714)